ONTOLOGY,TERM,N,DE,P.DE,FDR
BP,regulation of heterotypic cell-cell adhesion,26,4,5.39983730160189e-05,1
BP,regulation of leukocyte cell-cell adhesion,328,9,0.000255489464042054,1
BP,regulation of cell-cell adhesion,438,11,0.000345712568092537,1
BP,regulation of T cell activation,331,9,0.000362977300996037,1
BP,T cell activation,482,11,0.000405272869410917,1
BP,T cell differentiation,253,8,0.000452631041646784,1
BP,leukocyte cell-cell adhesion,363,9,0.000515345341199699,1
BP,regulation of lymphocyte activation,440,10,0.000598235627223053,1
BP,positive regulation of T cell activation,213,7,0.000673311033315337,1
BP,positive regulation of cell adhesion,426,11,0.00067962453553558,1
BP,lymphocyte differentiation,367,9,0.000846983828848144,1
BP,response to leukemia inhibitory factor,97,5,0.000882567714671949,1
BP,cellular response to leukemia inhibitory factor,97,5,0.000882567714671949,1
BP,positive regulation of cell-cell adhesion,278,8,0.000949252367157515,1
BP,positive regulation of leukocyte cell-cell adhesion,234,7,0.0011345711730652,1
BP,muscle organ development,405,10,0.00129549783218145,1
BP,heterotypic cell-cell adhesion,62,4,0.00136378880682862,1
BP,alpha-beta T cell differentiation,106,5,0.00146222971814628,1
BP,lymphocyte activation,687,12,0.00185660121739796,1
BP,negative regulation of telomere capping,8,2,0.00193664447471233,1
BP,regulation of leukocyte activation,528,10,0.00207863805058966,1
BP,regulation of cell adhesion,734,14,0.00267600144903997,1
BP,dCTP catabolic process,1,1,0.00287222205980842,1
BP,dCTP metabolic process,1,1,0.00287222205980842,1
BP,negative regulation of heterotypic cell-cell adhesion,11,2,0.00293088109237065,1
BP,regulation of cell-cell adhesion involved in gastrulation,11,2,0.00293088109237065,1
BP,peptidyl-serine autophosphorylation,8,2,0.00304289715152776,1
BP,positive regulation of lymphocyte activation,282,7,0.00311011913357507,1
BP,cell-cell adhesion involved in gastrulation,12,2,0.00322953181720459,1
BP,alpha-beta T cell activation,145,5,0.00386114194990942,1
BP,CD4-positive, alpha-beta T cell activation,97,4,0.00414863586987912,1
BP,regulation of cell activation,573,10,0.00422223437746275,1
BP,positive regulation of T cell differentiation,92,4,0.00443076480268658,1
BP,negative regulation of transforming growth factor beta receptor signaling pathway,87,4,0.00461351754975892,1
BP,regulation of T cell differentiation,150,5,0.00477615974221296,1
BP,seryl-tRNA aminoacylation,2,1,0.00490955486381346,1
BP,lymphocyte proliferation,282,6,0.00505677987469921,1
BP,mononuclear cell proliferation,285,6,0.00522637431919538,1
BP,negative regulation of cellular response to transforming growth factor beta stimulus,89,4,0.00529372825273733,1
BP,positive regulation of leukocyte activation,329,7,0.00577468175291598,1
BP,thymus development,46,3,0.00652919927574737,1
BP,T cell costimulation,55,3,0.00659969573929062,1
BP,lymphocyte costimulation,57,3,0.00684594520317709,1
BP,adipose tissue development,44,3,0.00694564446030449,1
BP,negative regulation of I-kappaB kinase/NF-kappaB signaling,53,3,0.00697054511615628,1
BP,positive regulation of cell activation,344,7,0.00708323962537446,1
BP,post-embryonic development,86,4,0.00712783707802625,1
BP,positive regulation of heterotypic cell-cell adhesion,16,2,0.00730414976623992,1
BP,positive regulation of lymphocyte differentiation,104,4,0.00741937463048292,1
BP,V(D)J recombination,15,2,0.00769590528010178,1
BP,hematopoietic or lymphoid organ development,961,14,0.00771263268658842,1
BP,cell activation,1402,17,0.00808368493035194,1
BP,leukocyte proliferation,312,6,0.00852355111433788,1
BP,eukaryotic translation initiation factor 2 complex assembly,1,1,0.00861678655949224,1
BP,phosphatidylinositol-3-phosphate biosynthetic process,14,2,0.00869519636036669,1
BP,I-kappaB kinase/NF-kappaB signaling,286,6,0.00876994127028492,1
BP,negative regulation of striated muscle tissue development,61,3,0.00892530305370903,1
BP,regulation of lymphocyte differentiation,180,5,0.00895212817111212,1
BP,selenocysteinyl-tRNA(Sec) biosynthetic process,4,1,0.00917495506529747,1
BP,negative regulation of muscle organ development,62,3,0.00964510896585894,1
BP,positive regulation of autophagy in response to ER overload,1,1,0.00971128184852384,1
BP,regulation of toll-like receptor signaling pathway,72,3,0.0100611842054211,1
BP,leukocyte activation,1241,15,0.0101858927756617,1
BP,pyrimidine nucleoside triphosphate catabolic process,3,1,0.0103192086851329,1
BP,pyrimidine deoxyribonucleoside triphosphate catabolic process,3,1,0.0103192086851329,1
BP,negative regulation of muscle tissue development,64,3,0.0110774702096848,1
BP,immune system development,1016,14,0.0114220517577713,1
BP,leukocyte differentiation,537,9,0.0122267381639128,1
BP,toll-like receptor signaling pathway,150,4,0.0125525782330922,1
BP,negative regulation of 3'-UTR-mediated mRNA stabilization,1,1,0.0134624878687632,1
BP,negative regulation of cardiac muscle cell proliferation,23,2,0.0136550701763891,1
BP,regulation of tolerance induction to self antigen,1,1,0.0138814646629198,1
BP,positive regulation of tolerance induction to self antigen,1,1,0.0138814646629198,1
BP,inferior endocardial cushion morphogenesis,1,1,0.0138814646629198,1
BP,T cell receptor signaling pathway,197,5,0.0140694608890622,1
BP,regulation of cellular response to gamma radiation,1,1,0.0143794669080924,1
BP,tarsal gland development,1,1,0.0151489401449408,1
BP,uterine gland development,1,1,0.0151489401449408,1
BP,zinc ion homeostasis,39,2,0.0153282232824664,1
BP,leukocyte homeostasis,86,3,0.0156521140776133,1
BP,positive regulation of apoptotic process by virus,2,1,0.0157535092303631,1
BP,B cell proliferation,97,3,0.0157847360686215,1
BP,regulation of B cell tolerance induction,2,1,0.0159648867506726,1
BP,positive regulation of B cell tolerance induction,2,1,0.0159648867506726,1
BP,trachea development,19,2,0.0162660792040814,1
BP,snRNA (adenine-N6)-methylation,2,1,0.0163852248475385,1
BP,pre-B cell allelic exclusion,3,1,0.0167937296276672,1
BP,signal transduction involved in mitotic G2 DNA damage checkpoint,3,1,0.0169623332015493,1
BP,autocrine signaling,8,1,0.0170560814335467,1
BP,regulation of estrogen receptor binding,3,1,0.0172331915764786,1
BP,negative regulation of estrogen receptor binding,3,1,0.0172331915764786,1
BP,negative regulation of dendritic cell antigen processing and presentation,4,1,0.0174103340049108,1
BP,regulation of transforming growth factor beta receptor signaling pathway,127,4,0.0175038695477314,1
BP,lymphocyte migration into lymph node,2,1,0.0175108615376739,1
BP,CD4-positive, alpha-beta T cell differentiation,78,3,0.0177705855179989,1
BP,selenocysteine metabolic process,4,1,0.0179505572465786,1
BP,zinc ion import into organelle,2,1,0.0182576400286431,1
BP,zinc ion import into synaptic vesicle,2,1,0.0182576400286431,1
BP,corticosterone secretion,5,1,0.0189589565213772,1
BP,regulation of cellular response to transforming growth factor beta stimulus,129,4,0.0190996365259249,1
BP,primary adaptive immune response,1,1,0.0191276937162079,1
BP,primary adaptive immune response involving T cells and B cells,1,1,0.0191276937162079,1
BP,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,133,4,0.0194009379679708,1
BP,negative regulation of immune system process,460,7,0.0197039969432041,1
BP,regulation of telomere capping,26,2,0.0200570630300724,1
BP,meiosis I,118,3,0.0201659412515196,1
BP,regulation of T cell differentiation in thymus,27,2,0.020355887227316,1
BP,telomerase catalytic core complex assembly,2,1,0.020596257487799,1
BP,regulation of telomerase catalytic core complex assembly,2,1,0.020596257487799,1
BP,positive regulation of telomerase catalytic core complex assembly,2,1,0.020596257487799,1
BP,trachea submucosa development,2,1,0.0206424103999203,1
BP,trachea gland development,2,1,0.0206424103999203,1
BP,positive regulation by symbiont of host programmed cell death,3,1,0.0207582396668109,1
BP,positive regulation by symbiont of host apoptotic process,3,1,0.0207582396668109,1
BP,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,3,1,0.0207582396668109,1
BP,cell-cell adhesion,881,13,0.0207855372914644,1
BP,negative regulation of neutrophil apoptotic process,2,1,0.0209211523619337,1
BP,miRNA transport,3,1,0.0210789129724544,1
BP,muscle structure development,678,11,0.0211083478786261,1
BP,immune system process,2967,27,0.0215153351081412,1
BP,bronchus morphogenesis,2,1,0.0216323664700432,1
BP,lens fiber cell apoptotic process,4,1,0.0218815049849186,1
BP,regulation of DNA damage response, signal transduction by p53 class mediator,34,2,0.0219061544493322,1
BP,killing by symbiont of host cells,4,1,0.021943223580142,1
BP,positive regulation of Ras protein signal transduction,69,3,0.0221296892891415,1
BP,meiosis I cell cycle process,123,3,0.0222606404948835,1
BP,T cell differentiation in thymus,76,3,0.0222981191133513,1
BP,peptidyl-threonine phosphorylation,117,4,0.0224103561262031,1
BP,retrograde transport, plasma membrane to Golgi,2,1,0.022638222066515,1
BP,regulation of immune system process,1512,16,0.0226718678551243,1
BP,apoptotic process involved in morphogenesis,26,2,0.0233815659711888,1
BP,regulation of I-kappaB kinase/NF-kappaB signaling,252,5,0.0234420244686666,1
BP,protein initiator methionine removal,3,1,0.0234985772508666,1
BP,regulation of chaperone-mediated protein folding,5,1,0.0236129368280839,1
BP,establishment of RNA localization to telomere,3,1,0.0246096733109158,1
BP,establishment of protein-containing complex localization to telomere,3,1,0.0246096733109158,1
BP,leukocyte apoptotic process,107,3,0.0246184781319327,1
BP,regulation of pattern recognition receptor signaling pathway,97,3,0.0247281941649911,1
BP,S-adenosylmethionine biosynthetic process,4,1,0.0249684988610193,1
BP,spermine catabolic process,2,1,0.0250692013163216,1
BP,positive regulation of nitrogen compound metabolic process,3174,32,0.0252077211501165,1
BP,chemokine (C-C motif) ligand 21 signaling pathway,4,1,0.0252115390727973,1
BP,T cell apoptotic process,49,2,0.0253122443691273,1
BP,negative regulation of toll-like receptor signaling pathway,43,2,0.02554314981057,1
BP,secondary palate development,24,2,0.0258038113881634,1
BP,response to selenium ion,10,1,0.0260023255592474,1
BP,negative regulation of telomere maintenance,36,2,0.0260476945569622,1
BP,spleen development,34,2,0.026378681937693,1
BP,positive regulation of response to interferon-gamma,6,1,0.0263939096435098,1
BP,positive regulation of interferon-gamma-mediated signaling pathway,6,1,0.0263939096435098,1
BP,negative regulation of cardiac muscle tissue growth,34,2,0.0267555122581832,1
BP,negative regulation of heart growth,34,2,0.0267555122581832,1
BP,establishment of RNA localization,200,4,0.026902137598991,1
BP,positive regulation of leukocyte differentiation,158,4,0.0272767528720499,1
BP,response to sterol,35,2,0.027652418964808,1
BP,hemopoiesis,920,12,0.0278557506120812,1
BP,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,2,1,0.0279559371918049,1
BP,polyamine catabolic process,4,1,0.0281101802170175,1
BP,pre-B cell differentiation,5,1,0.0283964745196018,1
BP,negative regulation of protein-containing complex assembly,141,4,0.0286949839814925,1
BP,positive regulation of small GTPase mediated signal transduction,76,3,0.0288873825843773,1
BP,DNA protection,5,1,0.0289920314461271,1
BP,immune response,1995,18,0.0290097157882511,1
BP,growth plate cartilage chondrocyte growth,3,1,0.0291234463011819,1
BP,apoptotic process involved in embryonic digit morphogenesis,3,1,0.0293260249796899,1
BP,peptidyl-threonine modification,126,4,0.0293882926007117,1
BP,negative regulation of leukocyte apoptotic process,48,2,0.0296541505662601,1
BP,negative regulation of cell-cell adhesion mediated by integrin,2,1,0.0296715815692979,1
BP,negative regulation of cellular process,5077,45,0.0298999297605572,1
BP,B cell tolerance induction,3,1,0.0299872422884414,1
BP,NADP biosynthetic process,3,1,0.030334997823823,1
BP,regulation of response to gamma radiation,2,1,0.0308693689657445,1
BP,positive regulation of DNA catabolic process,6,1,0.0308840577177797,1
BP,negative regulation of interleukin-13 production,6,1,0.0309586283332888,1
BP,snRNA modification,7,1,0.0310953274069377,1
BP,reciprocal meiotic recombination,54,2,0.031447402754629,1
BP,regulation of striated muscle tissue development,153,4,0.0320220118464742,1
BP,positive regulation of cell motility,589,9,0.0320294817820289,1
BP,regulation of nitrogen compound metabolic process,5894,48,0.0320757155821544,1
BP,homologous recombination,55,2,0.032490172369324,1
BP,skeletal muscle tissue development,157,4,0.0326825343664589,1
BP,branching involved in blood vessel morphogenesis,36,2,0.0329525173387195,1
BP,positive regulation of ARF protein signal transduction,2,1,0.0331137924726125,1
BP,lipoprotein metabolic process,134,3,0.0331167592505154,1
BP,pyrimidine deoxyribonucleoside triphosphate metabolic process,7,1,0.0332292275811282,1
BP,antigen receptor-mediated signaling pathway,245,5,0.0335161505335055,1
BP,negative regulation of protein polymerization,79,3,0.0336766549011073,1
BP,actin modification,4,1,0.0336903405845185,1
BP,deoxyribonucleoside triphosphate catabolic process,9,1,0.0337015975989468,1
BP,regulation of muscle organ development,157,4,0.0338165760210815,1
BP,histone H3-K36 dimethylation,4,1,0.0343733859188579,1
BP,negative regulation of interleukin-5 production,7,1,0.0346837693162276,1
BP,regulation of muscle tissue development,156,4,0.034839369471337,1
BP,pattern recognition receptor signaling pathway,199,4,0.0348466649099789,1
BP,positive regulation of T cell tolerance induction,6,1,0.03491930219419,1
BP,mast cell degranulation,46,2,0.0350672622386249,1
BP,negative regulation of vascular endothelial growth factor production,31,1,0.0357228766341592,1
BP,mast cell activation involved in immune response,47,2,0.0360312592735163,1
BP,formation of radial glial scaffolds,4,1,0.0360410774067382,1
BP,multicellular organism growth,150,4,0.0360635896594702,1
BP,negative regulation of protein binding,106,3,0.036327641609479,1
BP,positive regulation of locomotion,603,9,0.036645464414652,1
BP,cellular response to cytokine stimulus,1120,12,0.0367516999833559,1
BP,telomere capping,53,2,0.0374105061410039,1
BP,protein localization to microtubule plus-end,5,1,0.0375592790077401,1
BP,protein localization to microtubule end,5,1,0.0375592790077401,1
BP,positive regulation of MHC class I biosynthetic process,5,1,0.0376732814534312,1
BP,mast cell mediated immunity,48,2,0.0379396282292416,1
BP,rRNA base methylation,10,1,0.0383494503489346,1
BP,face morphogenesis,30,2,0.0386925655619335,1
BP,striated muscle tissue development,388,7,0.0389595605034685,1
BP,positive regulation of CD4-positive, alpha-beta T cell proliferation,5,1,0.0390235373280454,1
BP,negative regulation of cardiac muscle tissue development,45,2,0.0394013518984651,1
BP,vitamin A metabolic process,8,1,0.0395160489969685,1
BP,positive regulation of cellular component movement,607,9,0.0397851269959106,1
BP,common myeloid progenitor cell proliferation,7,1,0.0399955338139518,1
BP,signal transduction by trans-phosphorylation,3,1,0.0402357995630626,1
BP,beta-catenin-TCF complex assembly,30,2,0.0403059762582446,1
BP,MHC class I biosynthetic process,7,1,0.0403098698088823,1
BP,regulation of MHC class I biosynthetic process,7,1,0.0403098698088823,1
BP,lymphocyte migration into lymphoid organs,6,1,0.0405585377213624,1
BP,dsRNA transport,3,1,0.0406884319415027,1
BP,cellular response to nitrosative stress,6,1,0.0411042920414936,1
BP,modulation by virus of host apoptotic process,4,1,0.0412370655270776,1
BP,histone H3-K4 demethylation, trimethyl-H3-K4-specific,5,1,0.0412913404319601,1
BP,negative regulation of antigen processing and presentation,9,1,0.0413023401949402,1
BP,apoptotic process involved in blood vessel morphogenesis,5,1,0.0413635443265965,1
BP,positive regulation of metalloendopeptidase activity,9,1,0.0413965288216502,1
BP,histone H3-K23 acetylation,5,1,0.0415100820853643,1
BP,regulation of cellular protein metabolic process,2738,26,0.0415715573842147,1
BP,positive regulation of skeletal muscle tissue regeneration,5,1,0.0416233951924832,1
BP,RNA localization,233,4,0.0417247671808873,1
BP,negative regulation of T cell mediated cytotoxicity,7,1,0.0418129567135113,1
BP,negative regulation of immature T cell proliferation in thymus,4,1,0.0419869861591736,1
BP,positive regulation of histone phosphorylation,8,1,0.0421895346059806,1
BP,spermine metabolic process,5,1,0.0423858032420141,1
BP,negative regulation of immature T cell proliferation,5,1,0.0431430068066635,1
BP,chondrocyte hypertrophy,5,1,0.0434600740069974,1
BP,skeletal muscle organ development,166,4,0.0435229206772169,1
BP,positive regulation of tolerance induction,9,1,0.0435894675502676,1
BP,negative regulation of apoptotic process in bone marrow cell,6,1,0.0438239338066993,1
BP,inflammatory response to antigenic stimulus,64,2,0.0439509259710276,1
BP,telomerase holoenzyme complex assembly,6,1,0.044019356728742,1
BP,regulation of cellular metabolic process,6297,50,0.0442056842415562,1
BP,glucocorticoid secretion,10,1,0.0445825003067782,1
BP,regulation of apoptotic process in bone marrow cell,7,1,0.0448212454078475,1
BP,regulation of skeletal muscle tissue regeneration,8,1,0.0453090523163895,1
BP,regulation of protein metabolic process,2875,27,0.0454436329955259,1
BP,early endosome to recycling endosome transport,4,1,0.0458608910452356,1
BP,regulation of hemopoiesis,492,7,0.045982822520798,1
BP,histone H3-K9 methylation,38,2,0.0465896456615982,1
BP,ubiquitin-dependent SMAD protein catabolic process,6,1,0.0466147807389202,1
BP,nuclear matrix organization,3,1,0.0467856970391943,1
BP,nuclear matrix anchoring at nuclear membrane,3,1,0.0467856970391943,1
BP,positive regulation of chemokine (C-X-C motif) ligand 2 production,9,1,0.0469527197848192,1
BP,negative regulation of interleukin-4 production,8,1,0.0476632253833455,1
BP,modulation of programmed cell death in other organism,6,1,0.0479126646532845,1
BP,modulation of apoptotic process in other organism,6,1,0.0479126646532845,1
BP,modulation by symbiont of host apoptotic process,6,1,0.0479126646532845,1
BP,modulation of programmed cell death in other organism involved in symbiotic interaction,6,1,0.0479126646532845,1
BP,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,6,1,0.0479126646532845,1
BP,positive regulation of IRE1-mediated unfolded protein response,7,1,0.0480194563271885,1
BP,positive regulation of epithelial cell migration,176,4,0.0482880337082582,1
BP,positive regulation of trophoblast cell migration,7,1,0.0485904496538222,1
BP,muscle tissue development,408,7,0.0486247008413775,1
BP,positive regulation of cell adhesion molecule production,8,1,0.0487312831614528,1
BP,head morphogenesis,35,2,0.0489473384727114,1
BP,negative regulation of cellular response to growth factor stimulus,182,4,0.0489663984970159,1
BP,regulation of telomere maintenance via telomerase,53,2,0.0491326207759916,1
BP,regulation of neutrophil apoptotic process,7,1,0.049356007546487,1
